Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0146 (3,650.00%)
Jan 8, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $1.9 million as of January 9, 2026. Its market cap has increased by 14,899.72% in one year.
Market Cap
1.90M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 1.90M, a decrease of -99.91%. That is a compound annual growth rate of -81.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.90M | 4,900.04% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |